Allspring Global Investments Holdings LLC Sells 27,075 Shares of Oscar Health, Inc. (NYSE:OSCR)

Allspring Global Investments Holdings LLC decreased its position in shares of Oscar Health, Inc. (NYSE:OSCR) by 24.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 81,999 shares of the company’s stock after selling 27,075 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Oscar Health were worth $1,111,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in OSCR. Creative Planning raised its stake in Oscar Health by 73.8% during the 3rd quarter. Creative Planning now owns 31,296 shares of the company’s stock worth $664,000 after acquiring an additional 13,286 shares during the period. Wealth Enhancement Advisory Services LLC raised its stake in Oscar Health by 7.5% during the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 12,028 shares of the company’s stock worth $255,000 after acquiring an additional 844 shares during the period. FCG Investment Co purchased a new stake in Oscar Health during the 3rd quarter valued at approximately $986,000. US Bancorp DE grew its holdings in Oscar Health by 115.9% during the 3rd quarter. US Bancorp DE now owns 24,784 shares of the company’s stock valued at $526,000 after buying an additional 13,305 shares in the last quarter. Finally, Janney Montgomery Scott LLC purchased a new stake in Oscar Health during the 3rd quarter valued at approximately $988,000. Institutional investors own 75.70% of the company’s stock.

Oscar Health Stock Down 7.8 %

NYSE OSCR opened at $14.81 on Monday. The business has a fifty day moving average price of $14.82 and a 200 day moving average price of $16.68. Oscar Health, Inc. has a one year low of $12.43 and a one year high of $23.79. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. The company has a market cap of $3.66 billion, a P/E ratio of -740.33 and a beta of 1.73.

Oscar Health (NYSE:OSCR) last issued its earnings results on Tuesday, February 4th. The company reported ($0.62) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. Research analysts anticipate that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the stock. Jefferies Financial Group assumed coverage on shares of Oscar Health in a report on Tuesday, December 10th. They set an “underperform” rating and a $12.00 price objective for the company. Bank of America lowered shares of Oscar Health from a “neutral” rating to an “underperform” rating and cut their price objective for the company from $21.00 to $13.50 in a report on Wednesday, November 6th. Two analysts have rated the stock with a sell rating, two have issued a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $21.56.

Insider Buying and Selling at Oscar Health

In related news, CAO Victoria Baltrus sold 8,078 shares of the business’s stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total transaction of $146,050.24. Following the completion of the sale, the chief accounting officer now owns 146,036 shares in the company, valued at $2,640,330.88. The trade was a 5.24 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Mario Schlosser sold 6,516 shares of the business’s stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total value of $117,809.28. Following the completion of the sale, the insider now owns 81,962 shares of the company’s stock, valued at approximately $1,481,872.96. This represents a 7.36 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 78,610 shares of company stock valued at $1,421,269 in the last quarter. Corporate insiders own 25.11% of the company’s stock.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.